Selected Publications

Academic Article

Year Title Altmetric
2019 ACR Appropriateness Criteria® Post-Treatment Follow-up and Active Surveillance of Clinically Localized Renal Cell CancerJournal of the American College of Radiology.  16:S399-S416. 2019
2019 Screening of bone density at CT: An overlooked opportunityRadiology.  291:368-369. 2019
2019 Active surveillance versus nephron-sparing surgery for a Bosniak IIF or III renal cyst: A cost-effectiveness analysisInternational Journal of Molecular Medicine.  212:830-838. 2019
2019 Standardized report template for indeterminate renal masses at CT and MRI: a collaborative product of the SAR Disease-Focused Panel on Renal Cell Carcinoma.Journal of General and Applied Microbiology.  44:1423-1429. 2019
2019 Opportunistic bone density screening for the abdominal radiologist using colored CT images: a pilot retrospective studyJournal of General and Applied Microbiology.  44:775-782. 2019
2019 Bosniak classification of cystic renal masses, version 2019: An update proposal and needs assessmentRadiology.  292:475-488. 2019
2019 Current imaging techniques for noninvasive staging of hepatic fibrosisInternational Journal of Molecular Medicine.  213:77-89. 2019
2018 Enter the era of quantitative liver CTRadiology.  289:708-709. 2018
2018 ACR Appropriateness Criteria® Acute PyelonephritisJournal of the American College of Radiology.  15:S232-S239. 2018
2018 Correction to: Multi-institutional analysis of CT and MRI reports evaluating indeterminate renal masses: comparison to a national survey investigating desired report elements.Journal of General and Applied Microbiology.  43:3206. 2018
2018 Society of Abdominal Radiology disease-focused panel on renal cell carcinoma: update on past, current, and future goals.Journal of General and Applied Microbiology.  43:2213-2220. 2018
2018 Precision analysis of a quantitative ct liver surface nodularity scoreJournal of General and Applied Microbiology.  43:3307-3316. 2018
2018 Multi-institutional analysis of CT and MRI reports evaluating indeterminate renal masses: comparison to a national survey investigating desired report elements.Journal of General and Applied Microbiology.  43:3493-3502. 2018
2018 A tool to visualize and analyze perfusion data: Development and application of the R package “CTP”Physical and Occupational Therapy in Pediatrics.  153:11-17. 2018
2018 Radiology Research Funding: Current State and Future OpportunitiesSeminars in Cutaneous Medicine and Surgery.  25:26-39. 2018
2017 ACR Appropriateness Criteria® Renal Transplant DysfunctionJournal of the American College of Radiology.  14:S272-S281. 2017
2017 Reporting standards for the imaging-based diagnosis of renal masses on CT and MRI: a national survey of academic abdominal radiologists and urologistsJournal of General and Applied Microbiology.  42:1229-1240. 2017
2017 Feasibility and reproducibility of liver surface nodularity quantification for the assessment of liver cirrhosis using CT and MRI.European Journal of Radiology Open.  4:95-100. 2017
2016 Accuracy of Liver Surface Nodularity Quantification on MDCT as a Noninvasive Biomarker for Staging Hepatic FibrosisInternational Journal of Molecular Medicine.  207:1194-1199. 2016
2016 Metastatic renal cell carcinoma imaging evaluation in the era of anti-angiogenic therapiesJournal of General and Applied Microbiology.  41:1086-1099. 2016
2016 Stereoscopic vascular models of the head and neck: A computed tomography angiography visualizationJournal of Engineering Science and Technology.  9:179-185. 2016
2016 Vascular tumor burden as a new quantitative CT imaging biomarker for predicting metastatic RCC response to antiangiogenic therapy.Journal of Clinical Oncology.  34:595-595. 2016
2015 Increased visceral to subcutaneous fat ratio is associated with decreased overall survival in patients with metastatic melanoma receiving anti-angiogenic therapySurgical Oncology.  24:353-358. 2015
2015 Outcomes and complications related to the management of bosniak cystic renal lesionsInternational Journal of Molecular Medicine.  204:W550-W556. 2015
2013 Utilizing pre-therapy clinical schema and initial CT changes to predict progression-free survival in patients with metastatic renal cell carcinoma on VEGF-targeted therapy: A preliminary analysisUrologic Oncology: Seminars and Original Investigations.  31:1283-1291. 2013
2013 Development of a Clinical Prediction Model for Assessment of Malignancy Risk in Bosniak III Renal LesionsUrology.  82:630-635. 2013
2013 Increased plasma levels of soluble vascular endothelial growth factor receptor 1 (sFlt-1) in women by moderate exercise and increased plasma levels of vascular endothelial growth factor in overweight/obese womenEuropean Journal of Cancer Prevention.  22:83-89. 2013
2011 Gd-EOB-DTPA as a Functional MR Cholangiography Contrast Agent: Imaging Gallbladder Filling in Patients With and Without Hepatobiliary DysfunctionJournal of Computer Assisted Tomography.  35:439-445. 2011
2011 Clinical utility of image-guided chest wall mass biopsy: results in 28 patientsCancer Biomarkers.  11:42-47. 2011
2010 Morphology, Attenuation, Size, and Structure (MASS) Criteria: Assessing Response and Predicting Clinical Outcome in Metastatic Renal Cell Carcinoma on Antiangiogenic Targeted TherapyInternational Journal of Molecular Medicine.  194:1470-1478. 2010
2010 Assessing Tumor Response and Detecting Recurrence in Metastatic Renal Cell Carcinoma on Targeted Therapy: Importance of Size and Attenuation on Contrast-Enhanced CTInternational Journal of Molecular Medicine.  194:157-165. 2010
2003 A Biochemical Characterization of the Adeno-associated Virus Rep40 HelicaseJournal of Biological Chemistry.  278:34011-34017. 2003
Comparative Effectiveness of Tumor Response Assessment Methods: Standard of Care Versus Computer-Assisted Response Evaluation.JCO Clinical Cancer Informatics.  1:1-16.

Education And Training

  • Doctor of Medicine, Medical College of Ohio 2004
  • Doctor of Philosophy in Cell / Cellular and Molecular Biology, Medical College of Ohio 2000
  • Riverside Methodist Hospital, Internship 2005
  • Cleveland Clinic Foundation, Residency 2009
  • Cleveland Clinic Foundation, Postdoctoral Fellowship 2010
  • Full Name

  • Andrew Smith